- Популярные видео
- Авто
- Видео-блоги
- ДТП, аварии
- Для маленьких
- Еда, напитки
- Животные
- Закон и право
- Знаменитости
- Игры
- Искусство
- Комедии
- Красота, мода
- Кулинария, рецепты
- Люди
- Мото
- Музыка
- Мультфильмы
- Наука, технологии
- Новости
- Образование
- Политика
- Праздники
- Приколы
- Природа
- Происшествия
- Путешествия
- Развлечения
- Ржач
- Семья
- Сериалы
- Спорт
- Стиль жизни
- ТВ передачи
- Танцы
- Технологии
- Товары
- Ужасы
- Фильмы
- Шоу-бизнес
- Юмор
Liquid Biopsy Diagnostics 🩸🧪 | Masterclass with Klaus Pantel & Catherine Alix-Panabières
Join Klaus Pantel, Director of the Institute of Tumor Biology at the University Medical Center Hamburg-Eppendorf (UKE), and Catherine Alix-Panabières, Professor of Oncology at the University of Montpellier, for an in-depth masterclass on Liquid Biopsy Diagnostics (LBx).
As internationally recognized pioneers in circulating tumor cell (CTC) research and liquid biopsy technologies, they provide a comprehensive overview of how blood-based diagnostics are transforming cancer detection, monitoring, and treatment strategies.
This masterclass explores the scientific foundations, clinical applications, and future potential of liquid biopsy - from early cancer detection and minimal residual disease to tumor dormancy and immuno-oncology.
Chapters:
00:00 Introduction and the concept of liquid biopsy
12:58 Early detection of cancer
15:10 Detection of minimal residual cancer
17:50 Primary tumor-derived information and metastatic relapse
20:43 Detection of tumor-of-origin
22:27 Clinical implementation
26:18 The metastatic cascade
28:15 Biology of CTCs
30:34 Where to do Liquid Biopsy
35:55 Liquid biopsy and immuno-oncology
42:36 Tumor Dormancy
46:20 When to perform Liquid Biopsy
47:51 Establishment of CTC lines
52:22 Clinical applications of CTCs
PANCAID is an international research consortium aiming to develop a minimally invasive blood test using liquid biopsy to detect pancreatic cancer to facilitate early detection of the cancer and its precursors. With 20 members from eight countries, the project has received funding for five years to potentially revolutionize current pancreatic cancer diagnosis methods and improve patient outcomes.
The project has received funding for a duration of five years and started in January 2023.
🌐 More info: https://www.pancaid-project.eu
🤳 Follow us on social media:
LinkedIn: https://www.linkedin.com/company/pancaid/
X: https://twitter.com/PANCAID_EU
Instagram: https://www.instagram.com/pancaid_eu/
🇪🇺 Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Production: Tamara Berghammer, concentris
https://www.concentris.de/en/eu-project-management-services/
(c) PANCAID 2026
Видео Liquid Biopsy Diagnostics 🩸🧪 | Masterclass with Klaus Pantel & Catherine Alix-Panabières канала PANCAID
As internationally recognized pioneers in circulating tumor cell (CTC) research and liquid biopsy technologies, they provide a comprehensive overview of how blood-based diagnostics are transforming cancer detection, monitoring, and treatment strategies.
This masterclass explores the scientific foundations, clinical applications, and future potential of liquid biopsy - from early cancer detection and minimal residual disease to tumor dormancy and immuno-oncology.
Chapters:
00:00 Introduction and the concept of liquid biopsy
12:58 Early detection of cancer
15:10 Detection of minimal residual cancer
17:50 Primary tumor-derived information and metastatic relapse
20:43 Detection of tumor-of-origin
22:27 Clinical implementation
26:18 The metastatic cascade
28:15 Biology of CTCs
30:34 Where to do Liquid Biopsy
35:55 Liquid biopsy and immuno-oncology
42:36 Tumor Dormancy
46:20 When to perform Liquid Biopsy
47:51 Establishment of CTC lines
52:22 Clinical applications of CTCs
PANCAID is an international research consortium aiming to develop a minimally invasive blood test using liquid biopsy to detect pancreatic cancer to facilitate early detection of the cancer and its precursors. With 20 members from eight countries, the project has received funding for five years to potentially revolutionize current pancreatic cancer diagnosis methods and improve patient outcomes.
The project has received funding for a duration of five years and started in January 2023.
🌐 More info: https://www.pancaid-project.eu
🤳 Follow us on social media:
LinkedIn: https://www.linkedin.com/company/pancaid/
X: https://twitter.com/PANCAID_EU
Instagram: https://www.instagram.com/pancaid_eu/
🇪🇺 Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Production: Tamara Berghammer, concentris
https://www.concentris.de/en/eu-project-management-services/
(c) PANCAID 2026
Видео Liquid Biopsy Diagnostics 🩸🧪 | Masterclass with Klaus Pantel & Catherine Alix-Panabières канала PANCAID
Комментарии отсутствуют
Информация о видео
25 марта 2026 г. 22:01:30
00:56:36
Другие видео канала




















